Cargando…
Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years
PURPOSE: Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of 3 years have not been established yet. The objective of this study was to analyze...
Autores principales: | Park, Meerim, Han, Jung Woo, Hahn, Seung Min, Lee, Jun Ah, Kim, Joo-Young, Shin, Sang Hoon, Kim, Dong-Seok, Yoon, Hong In, Hong, Kyung Taek, Choi, Jung Yoon, Kang, Hyoung Jin, Shin, Hee Young, Phi, Ji Hoon, Kim, Seung-Ki, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Lim, Do Hoon, Shin, Hyung Jin, Kim, Hyery, Koh, Kyung-Nam, Im, Ho Joon, Ahn, Seung Do, Ra, Young-Shin, Baek, Hee-Jo, Kook, Hoon, Jung, Tae-Young, Choi, Hyoung Soo, Kim, Chae-Yong, Park, Hyeon Jin, Lyu, Chuhl Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053862/ https://www.ncbi.nlm.nih.gov/pubmed/33138347 http://dx.doi.org/10.4143/crt.2020.756 |
Ejemplares similares
-
Combination Treatment of CI-994 With Etoposide Potentiates Anticancer Effects Through a Topoisomerase II-Dependent Mechanism in Atypical Teratoid/Rhabdoid Tumor (AT/RT)
por: Kim, Hee Yeon, et al.
Publicado: (2021) -
Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor
por: Sung, Ki Woong, et al.
Publicado: (2016) -
LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
por: Choi, Seung Ah, et al.
Publicado: (2016) -
Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients
por: Hong, Kyung Taek, et al.
Publicado: (2020) -
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
por: Phi, Ji Hoon, et al.
Publicado: (2019)